Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Tobin NP"'
Autor:
Svedlund, J, Strell, C, Qian, XY, Zilkens, KJC, Tobin, NP, van den Bergh, J, Sieuwerts, Anieta, Nilsson, M
Publikováno v:
EBioMedicine, 48, 212-223. Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::fdaf79315d92e1380d37b69789d8fdc1
https://pure.eur.nl/en/publications/68079ec5-8c9d-4d96-98c6-b2eba22d3f28
https://pure.eur.nl/en/publications/68079ec5-8c9d-4d96-98c6-b2eba22d3f28
Autor:
Fonseca P; Department of Oncology and Pathology, Karolinska Institutet, U2, Bioclinicum J6:20, Solnavägen 30, 171 64, Solna, Stockholm, Sweden., Cui W; Department of Oncology and Pathology, Karolinska Institutet, U2, Bioclinicum J6:20, Solnavägen 30, 171 64, Solna, Stockholm, Sweden., Struyf N; Department of Oncology and Pathology, Karolinska Institutet, U2, Bioclinicum J6:20, Solnavägen 30, 171 64, Solna, Stockholm, Sweden.; Science for Life Laboratory, Tomtebodavägen 23a, 171 65, Stockholm, Sweden., Tong L; Department of Oncology and Pathology, Karolinska Institutet, U2, Bioclinicum J6:20, Solnavägen 30, 171 64, Solna, Stockholm, Sweden., Chaurasiya A; Department of Oncology and Pathology, Karolinska Institutet, U2, Bioclinicum J6:20, Solnavägen 30, 171 64, Solna, Stockholm, Sweden., Casagrande F; Department of Oncology and Pathology, Karolinska Institutet, U2, Bioclinicum J6:20, Solnavägen 30, 171 64, Solna, Stockholm, Sweden., Zhao H; Department of Oncology and Pathology, Karolinska Institutet, U2, Bioclinicum J6:20, Solnavägen 30, 171 64, Solna, Stockholm, Sweden., Fernando D; Department of Oncology and Pathology, Karolinska Institutet, U2, Bioclinicum J6:20, Solnavägen 30, 171 64, Solna, Stockholm, Sweden., Chen X; Department of Oncology and Pathology, Karolinska Institutet, U2, Bioclinicum J6:20, Solnavägen 30, 171 64, Solna, Stockholm, Sweden., Tobin NP; Department of Oncology and Pathology, Karolinska Institutet, U2, Bioclinicum J6:20, Solnavägen 30, 171 64, Solna, Stockholm, Sweden.; Breast Center, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden., Seashore-Ludlow B; Department of Oncology and Pathology, Karolinska Institutet, U2, Bioclinicum J6:20, Solnavägen 30, 171 64, Solna, Stockholm, Sweden.; Science for Life Laboratory, Tomtebodavägen 23a, 171 65, Stockholm, Sweden., Lundqvist A; Department of Oncology and Pathology, Karolinska Institutet, U2, Bioclinicum J6:20, Solnavägen 30, 171 64, Solna, Stockholm, Sweden., Hartman J; Department of Oncology and Pathology, Karolinska Institutet, U2, Bioclinicum J6:20, Solnavägen 30, 171 64, Solna, Stockholm, Sweden., Göndör A; Department of Oncology and Pathology, Karolinska Institutet, U2, Bioclinicum J6:20, Solnavägen 30, 171 64, Solna, Stockholm, Sweden.; Department of Clinical Molecular Biology, University of Oslo, Akershus Universitetssykehus, 1478, Lørenskog, Oslo, Norway., Östling P; Department of Oncology and Pathology, Karolinska Institutet, U2, Bioclinicum J6:20, Solnavägen 30, 171 64, Solna, Stockholm, Sweden.; Science for Life Laboratory, Tomtebodavägen 23a, 171 65, Stockholm, Sweden., Holmgren L; Department of Oncology and Pathology, Karolinska Institutet, U2, Bioclinicum J6:20, Solnavägen 30, 171 64, Solna, Stockholm, Sweden. lars.holmgren@ki.se.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Apr 09; Vol. 43 (1), pp. 107. Date of Electronic Publication: 2024 Apr 09.
Autor:
Castresana-Aguirre M; Department of Oncology and Pathology, BioClinicum, Karolinska Institutet and University Hospital, Visionsgatan 4, 171 64, Stockholm, Sweden.; Breast Center, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden., Johansson A; Department of Oncology and Pathology, BioClinicum, Karolinska Institutet and University Hospital, Visionsgatan 4, 171 64, Stockholm, Sweden.; Breast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Center, King's College London, London, UK., Matikas A; Department of Oncology and Pathology, BioClinicum, Karolinska Institutet and University Hospital, Visionsgatan 4, 171 64, Stockholm, Sweden.; Breast Center, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden., Foukakis T; Department of Oncology and Pathology, BioClinicum, Karolinska Institutet and University Hospital, Visionsgatan 4, 171 64, Stockholm, Sweden.; Breast Center, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden., Lindström LS; Department of Oncology and Pathology, BioClinicum, Karolinska Institutet and University Hospital, Visionsgatan 4, 171 64, Stockholm, Sweden.; Breast Center, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden., Tobin NP; Department of Oncology and Pathology, BioClinicum, Karolinska Institutet and University Hospital, Visionsgatan 4, 171 64, Stockholm, Sweden. nick.tobin@ki.se.; Breast Center, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden. nick.tobin@ki.se.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2024 Mar 07; Vol. 26 (1), pp. 38. Date of Electronic Publication: 2024 Mar 07.
Autor:
Tong L; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Kremer V; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Neo SY; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore., Liu Y; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Chen Y; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Medicine, Columbia University Irving Medical Center, New York, USA., Wagner AK; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden., Yang Y; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Chen Z; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Molecular Biology, Princeton University, New Jersey, USA., Seitz C; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Tobin NP; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Ligtenberg MA; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands., Alici E; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden., Chen X; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Haglund F; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Seliger B; Institute for Medical Immunology, Martin-Luther University Halle-Wittenberg, Halle, Germany.; Institute of Translational Immunology, Medical School Theodor Fontane, Brandenburg an der Havel, 14770, and Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany., Harmenberg U; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Colón E; Department of Women's and Children's Health, Karolinska Institutet and S:t Göran's Hospital-Unilabs, Stockholm, Sweden., Plogell AS; Department of Urology, Stockholm South General Hospital, Stockholm, Sweden., Liu LL; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Lundqvist A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
Cancer communications (London, England) [Cancer Commun (Lond)] 2023 Jul; Vol. 43 (7), pp. 855-859. Date of Electronic Publication: 2023 Jun 14.
Autor:
Johansson A; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Dar H; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., van 't Veer LJ; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA., Tobin NP; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Perez-Tenorio G; Department of Biomedical and Clinical Sciences and Department of Oncology, Linköping University, Linköping, Sweden., Nordenskjöld A; Institution of Clinical Sciences, Department of Oncology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden., Johansson U; Oncological Centre, Karolinska University Hospital, Stockholm, Sweden., Hartman J; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Skoog L; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Yau C; Buck Institute for Research on Aging, Novato, CA.; Department of Surgery, University of California San Francisco, San Francisco, CA., Benz CC; Buck Institute for Research on Aging, Novato, CA.; Department of Medicine, University of California San Francisco, San Francisco, CA., Esserman LJ; Department of Surgery, University of California San Francisco, San Francisco, CA., Stål O; Department of Biomedical and Clinical Sciences and Department of Oncology, Linköping University, Linköping, Sweden., Nordenskjöld B; Department of Biomedical and Clinical Sciences and Department of Oncology, Linköping University, Linköping, Sweden., Fornander T; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Lindström LS; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Dec 10; Vol. 40 (35), pp. 4071-4082. Date of Electronic Publication: 2022 Jul 21.
Autor:
Lundberg A; Department of Radiation Oncology, University of California at San Francisco, San Francisco, CA, USA.; Department of Oncology and Pathology, Karolinska Institutet and University Hospital, Stockholm, Sweden.; Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, USA.; Helen Diller Family Comperhensive Cancer Center, University of California at San Francisco, San Francisco, CA, USA., Yi JJJ; School of Biological Sciences, Nanyang Technological University, Singapore, 637551, Singapore., Lindström LS; Department of Oncology and Pathology, Karolinska Institutet and University Hospital, Stockholm, Sweden., Tobin NP; Department of Oncology and Pathology, Karolinska Institutet and University Hospital, Stockholm, Sweden. nick.tobin@ki.se.
Publikováno v:
NPJ precision oncology [NPJ Precis Oncol] 2022 Aug 20; Vol. 6 (1), pp. 59. Date of Electronic Publication: 2022 Aug 20.
Autor:
Johansson A; Department of Oncology and Pathology, Karolinska Institutet and University Hospital, Stockholm, Sweden., Yu NY; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden., Iftimi A; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden., Tobin NP; Department of Oncology and Pathology, Karolinska Institutet and University Hospital, Stockholm, Sweden., van 't Veer L; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.; Department of Pathology, University of California San Francisco, San Francisco, California, USA., Nordenskjöld B; Department of Biomedical and Clinical Sciences and Department of Oncology, Linköping University, Linköping, Sweden., Benz CC; Department of Medicine, University of California San Francisco, San Francisco, California, USA.; Buck Institute for Research on Aging, Novato, California, USA., Fornander T; Department of Oncology and Pathology, Karolinska Institutet and University Hospital, Stockholm, Sweden., Perez-Tenorio G; Department of Biomedical and Clinical Sciences and Department of Oncology, Linköping University, Linköping, Sweden., Stål O; Department of Biomedical and Clinical Sciences and Department of Oncology, Linköping University, Linköping, Sweden., Esserman LJ; Department of Surgery, University of California San Francisco, San Francisco, California, USA., Yau C; Buck Institute for Research on Aging, Novato, California, USA.; Department of Surgery, University of California San Francisco, San Francisco, California, USA., Lindström LS; Department of Oncology and Pathology, Karolinska Institutet and University Hospital, Stockholm, Sweden.
Publikováno v:
International journal of cancer [Int J Cancer] 2022 Jun 15; Vol. 150 (12), pp. 2072-2082. Date of Electronic Publication: 2022 Mar 07.
Autor:
Jeuken GS; Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH - Royal Institute of Technology, Solna, Sweden., Tobin NP; Department of Oncology and Pathology, Karolinska Institutet and University Hospital, Stockholm, Sweden., Käll L; Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH - Royal Institute of Technology, Solna, Sweden.
Publikováno v:
PLoS computational biology [PLoS Comput Biol] 2022 Mar 28; Vol. 18 (3), pp. e1010020. Date of Electronic Publication: 2022 Mar 28 (Print Publication: 2022).
Autor:
Ugalde-Morales E; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Electronic address: emilio.ugalde.morales@ki.se., Grassmann F; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Health and Medical University, Potsdam, Germany., Humphreys K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Swedish EScience Research Centre (SeRC), Karolinska Institutet Stockholm, SE-17177, Sweden., Li J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Human Genetics, Genome Institute of Singapore, Singapore, Singapore; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Eriksson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Tobin NP; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Lindström LS; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Vallon-Christersson J; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village 404-A2 Lund, SE-22381, Sweden; Lund University Cancer Center Lund, SE-22381, Sweden; CREATE Health Strategic Centre for Translational Cancer Research, Lund University Lund, SE-22381, Sweden., Borg Å; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village 404-A2 Lund, SE-22381, Sweden; Lund University Cancer Center Lund, SE-22381, Sweden; CREATE Health Strategic Centre for Translational Cancer Research, Lund University Lund, SE-22381, Sweden; Department of Clinical Sciences, SCIBLU Genomics, Lund University Lund, SE-22381, Sweden., Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Oncology, Södersjukhuset, Stockholm, Sweden., Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Feb; Vol. 162, pp. 194-205. Date of Electronic Publication: 2022 Jan 10.
Autor:
Yang M; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Johnsson P; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden., Bräutigam L; Comparative Medicine, Karolinska Institutet, Stockholm, Sweden., Yang XR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, MD., Thrane K; Department of Gene Technology, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden., Gao J; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Tobin NP; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Zhou Y; Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Yu R; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Nagy N; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden., Engström PG; Department of Biochemistry and Biophysics, National Bioinformatics Infrastructure Sweden, SciLifeLab, Stockholm University, Stockholm, Sweden., Tuominen R; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Eriksson H; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Karolinska University Hospital, Stockholm, Sweden., Lundeberg J; Department of Gene Technology, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden., Tucker MA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, MD., Goldstein AM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, MD., Egyhazi-Brage S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Zhao J; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. Electronic address: jian.zhao@ki.se., Cao Y; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Höiom V; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Karolinska University Hospital, Stockholm, Sweden. Electronic address: veronica.hoiom@ki.se.
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2022 Jan; Vol. 24 (1), pp. 157-169. Date of Electronic Publication: 2021 Nov 30.